Article ; Online: Effect of duration of sodium valproate therapy on bone mineral density and vitamin D levels.
2024 Volume 153, Page(s) 109733
Abstract: Objective: This study aimed to evaluate the impact of prolonged sodium valproate use on bone mineral density (BMD) and Vitamin D levels in pediatric epilepsy patients.: Methods: In a cross-sectional study conducted at the Epilepsy Clinic of Niloufer ... ...
Abstract | Objective: This study aimed to evaluate the impact of prolonged sodium valproate use on bone mineral density (BMD) and Vitamin D levels in pediatric epilepsy patients. Methods: In a cross-sectional study conducted at the Epilepsy Clinic of Niloufer Hospital, Hyderabad, India, 50 pediatric patients (aged 4-10 years) were recruited. The cohort comprised 30 epilepsy patients on sodium valproate treatment (cases) and 20 healthy siblings without epilepsy or valproate use (controls). BMD was assessed using dual-energy X-ray absorptiometry to measure height-adjusted total body less head Z-scores (TBLH Z-scores), and serum 25-hydroxyvitamin D levels were measured. Statistical analysis included independent samples t-tests, Mann-Whitney U tests, and Pearson correlation, with a preliminary power analysis ensuring adequate sample size. Results: Cases exhibited significantly lower BMD TBLH Z-scores (Mean = -1.543) compared to controls (Mean = 0.515, p <.001) and reduced Vitamin D levels (Mean = 9.17 for cases vs. 27.80 for controls, p <.001). A negative correlation was observed between the duration of sodium valproate use and both BMD Z-scores (r = -0.626, p <.001) and Vitamin D levels (r = -0.707, p <.001). Conclusions: The findings suggest a significant negative impact of prolonged sodium valproate use on both bone density and Vitamin D levels in pediatric patients. These results underscore the importance of monitoring and managing bone health in children receiving long-term sodium valproate therapy. |
---|---|
MeSH term(s) | Humans ; Child ; Bone Density ; Valproic Acid/adverse effects ; Cross-Sectional Studies ; Absorptiometry, Photon ; Vitamin D ; Epilepsy/drug therapy ; Epilepsy/chemically induced ; Vitamins |
Chemical Substances | Valproic Acid (614OI1Z5WI) ; Vitamin D (1406-16-2) ; Vitamins |
Language | English |
Publishing date | 2024-03-05 |
Publishing country | United States |
Document type | Journal Article |
ZDB-ID | 2010587-3 |
ISSN | 1525-5069 ; 1525-5050 |
ISSN (online) | 1525-5069 |
ISSN | 1525-5050 |
DOI | 10.1016/j.yebeh.2024.109733 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5289: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.